Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia

N Engl J Med. 2023 May 18;388(20):1911-1913. doi: 10.1056/NEJMc2302935.

Authors

Avivit Cahn¹, Hagit Shoyhet-Smoilovsky², Matan Fischer¹, Aviad Zick¹, Yael Riahi¹, Shulamit Levenberg², Gil Leibowitz³

Affiliations

¹ Hadassah Medical Center of Hebrew University of Jerusalem, Jerusalem, Israel.
² Technion-Israel Institute of Technology, Haifa, Israel.
³ Hadassah Medical Center of Hebrew University of Jerusalem, Jerusalem, Israel gleib@hadassah.org.il.

PMID: 37195951
DOI: 10.1056/NEJMc2302935

No abstract available

Publication types

Letter

MeSH terms

Class I Phosphatidylinositol 3-Kinases* / therapeutic use
Humans
Hypoglycemia* / drug therapy
Hypoglycemia* / etiology
Paraneoplastic Syndromes / complications
Thiazoles / therapeutic use

Substances

Alpelisib
Thiazoles
Class I Phosphatidylinositol 3-Kinases